SERMO is a virtual doctors' lounge, teaching hospital and international medical conference all rolled into one. Doctors come together in this unique online meeting place that facilitates authentic ...
Physicians listen to each other when it comes to drug ratings on Sermo's now two-year-old docs-only social media platform. (Getty/AndreyPopov) Just over two years in, physician social media platform ...
Sermo, a global social network for healthcare professionals, found in a recent physician poll that most patients listen to their doctors — or at least the doctors think so. In a survey involving 1,122 ...
NEW YORK, April 27, 2015 /PRNewswire/ -- 81 percent of US physicians polled on SERMO, the top social network for doctors, want Dr. Oz to resign from his faculty position at Columbia University or lose ...
NEW YORK--(BUSINESS WIRE)--Week two data of the Barometer study from 5,000 physicians in 30 countries conducted by Sermo reveals the emergence of treatment patterns. Sermo, the largest global ...
Cambridge, Mass.-based Sermo, an online social network with a twist, offers physicians the opportunity to ask for and offer advice free of charge. The catch: Well-heeled investors can pay to listen in ...
NEW YORK--(BUSINESS WIRE)--Since late March, healthcare data collection company and social platform for doctors, Sermo, has been surveying physicians worldwide about their experiences and perceptions ...
Sermo’s physician social network and Everyday Health’s digital health media network are sharing capabilities. The newly inked partnership hands control of joint market research projects to Sermo, ...
When physicians want thoughts on a certain drug, it’s not uncommon for them to stop a trusted colleague in the hallway and ask about its efficacy. But what if none of their colleagues are ...
CAMBRIDGE, Mass., Jan. 6 Sermo (http://www.sermo.com), the world's largest online physician's community, today announced a new Sermo Event(TM) Report assessing ...
Sermo Barometer Finds Nearly Half of Physicians Report Patients are Using Non-FDA Regulated Peptides
The 45th Sermo Barometer surveyed more than 500 U.S.-based physicians on how emerging peptide therapies are showing up in patient conversations. Nearly half (48%) reported that patients have disclosed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results